Actavis ready to buy Botox-maker Allergan in $66 billion
NEW YORK: Actavis has agreed to buy Botox-maker Allergan AGN 1.24% in $66 billion in a cash and stock deal ...
NEW YORK: Actavis has agreed to buy Botox-maker Allergan AGN 1.24% in $66 billion in a cash and stock deal ...
© 2011 Customs Today -World's first newspaper on customs. Customs Today.
© 2011 Customs Today -World's first newspaper on customs. Customs Today.